Alembic Pharmaceuticals Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations, 2015")'.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has informed the stock exchanges that it has sent a notice to specific shareholders whose equity shares are liable to be transferred to the Investor Education and Protection Fund (IEPF). The reason is that these shareholders have not claimed their dividends for seven consecutive years, starting from the unpaid dividend for FY 2017-2018 through FY 2023-2024. These shareholders have been asked to claim their unpaid dividends on or before 10th August 2025, failing which their shares will be transferred to the IEPF. Once transferred, shareholders can still reclaim the shares by filing Form IEPF-5 with the IEPF Authority. The company's Registrar and Transfer Agent handling the process is MUFG Intime India Private Limited (formerly Link Intime).
This is a routine regulatory compliance filing under SEBI Listing Regulations and does not have any material impact on the company or its stock price. However, the specific shareholders named in the notice must act before 10th August 2025 to claim their dividends and prevent their shares from being moved to the IEPF account.